First developed in the 1950s, beta blockers have been a mainstay in medicine for decades, used to treat everything from heart disease to stage fright to glaucoma. But some older classes of beta blockers are causing new concerns.
Nov 12, 2012
1
1
(HealthDay)—Taking too many medications at the same time could lead to repeated fainting episodes, a new study reveals.
Nov 5, 2012
0
0
Among patients with either coronary artery disease (CAD) risk factors only, known prior heart attack, or known CAD without heart attack, the use of beta-blockers was not associated with a lower risk of a composite of cardiovascular ...
Oct 2, 2012
0
0
(HealthDay)—Beta blockers (BBs) are effective as an early prophylactic pharmacologic treatment for patients with mild hypertrophic cardiomyopathy (HC) who have exercise-induced left ventricular outflow tract (LVOT) obstruction, ...
Sep 10, 2012
0
0
(HealthDay)—In a review that compared two common heart drugs against each other, researchers found no difference between atenolol and metoprolol in terms of preventing stroke, heart attack or heart failure for patients ...
Aug 27, 2012
1
0
The very oldest in our society are missing out on simple heart treatments which can prolong and improve their quality of life, Newcastle heart experts say.
Jul 24, 2012
0
0
(HealthDay) -- A reduction in central to brachial amplification induced by some antihypertensive drugs may result in lesser reductions in central than brachial systolic blood pressure, according to research published online ...
Jun 6, 2012
0
0
A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer. Published early online in CANCER, a peer-reviewed ...
May 14, 2012
0
0
A traditional treatment for heart failure appears to be equally protective in preventing death or hospitalization among African-American patients, as compared to white patients, according to a study at Henry Ford Hospital ...
May 9, 2012
0
0
Stressed people fall into habits and their behaviour is not goal-directed. That the neurotransmitter norepinephrine plays a decisive role here is now reported in the Journal of Neuroscience by scientists from Bochum led by ...
Nov 28, 2011
1
0
